Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
Recruiting · NCT06211166 · Registry updated 2024-01-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute leukemia, chronic myeloid leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasm, neoplasm | Recruiting | Not stated | 2024-01-18 | NCT06211166 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | 146 |